Chinese brain-computer interface company NeuroXess is gearing up for what it sees as the next phase of the industry: mass production.

China's NMPA granted Neuracle Medical Technology the world's first commercial approval for an invasive brain-computer interface, while NeuroXess runs

Chinese brain-computer interface company NeuroXess is gearing up for what it sees as the next phase of the industry: mass production.